City University of New York (CUNY)

CUNY Academic Works
Publications and Research

City College of New York

2015

Death Associated Protein Kinase (DAPK) -mediated
neurodegenerative mechanisms in nematode excitotoxicity
John S. Del Rosario
CUNY City College

Katherine Genevieve Feldmann
CUNY City College

Towfiq Ahmed
CUNY City College

Uzair Amjad
CUNY City College

BakKeung Ko
CUNY City College

See next page for additional authors

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/cc_pubs/393
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

Authors
John S. Del Rosario, Katherine Genevieve Feldmann, Towfiq Ahmed, Uzair Amjad, BakKeung Ko, JunHyung
An, Tauhid Mahmud, Maha Salama, Shirley Mei, Daniel Asemota, and Itzhak Mano

This article is available at CUNY Academic Works: https://academicworks.cuny.edu/cc_pubs/393

Del Rosario et al. BMC Neuroscience (2015) 16:25
DOI 10.1186/s12868-015-0158-2

RESEARCH ARTICLE

Open Access

Death Associated Protein Kinase (DAPK) -mediated
neurodegenerative mechanisms in nematode
excitotoxicity
John S Del Rosario1,2, Katherine Genevieve Feldmann1,3, Towfiq Ahmed4, Uzair Amjad5, BakKeung Ko4,2,
JunHyung An4, Tauhid Mahmud4, Maha Salama6, Shirley Mei6, Daniel Asemota6 and Itzhak Mano1,3*

Abstract
Background: Excitotoxicity (the toxic overstimulation of neurons by the excitatory transmitter Glutamate) is a central
process in widespread neurodegenerative conditions such as brain ischemia and chronic neurological diseases. Many
mechanisms have been suggested to mediate excitotoxicity, but their significance across diverse excitotoxic scenarios
remains unclear. Death Associated Protein Kinase (DAPK), a critical molecular switch that controls a range of key
signaling and cell death pathways, has been suggested to have an important role in excitotoxicity. However, the
molecular mechanism by which DAPK exerts its effect is controversial. A few distinct mechanisms have been suggested
by single (sometimes contradicting) studies, and a larger array of potential mechanisms is implicated by the extensive
interactome of DAPK.
Results: Here we analyze a well-characterized model of excitotoxicity in the nematode C. elegans to show that DAPK is
an important mediator of excitotoxic neurodegeneration across a large evolutionary distance. We further show that some
proposed mechanisms of DAPK’s action (modulation of synaptic strength, involvement of the DANGER-related
protein MAB-21, and autophagy) do not have a major role in nematode excitotoxicity. In contrast, Pin1/PINN-1
(a DAPK interaction-partner and a peptidyl-prolyl isomerase involved in chronic neurodegenerative conditions)
suppresses neurodegeneration in our excitotoxicity model.
Conclusions: Our studies highlight the prominence of DAPK and Pin1/PINN-1 as conserved mediators of cell
death processes in diverse scenarios of neurodegeneration.
Keywords: Ischemia, Glutamate, Excitotoxicity, Neurodegeneration, Death-Associated protein kinase,
Autophagy, Peptidyl prolyl isomerase Pin1

Background
Excitotoxicity is a neurodegenerative process believed to
be the central mediator of brain damage in acute conditions such as brain ischemia and traumatic injury, and an
important contributor to a range of chronic neurodegenerative diseases [1-4]. In excitotoxicity, the malfunction of
Glutamate (Glu) Transporters (GluTs) [5-7] causes accumulation of Glu in excitatory synapses and exaggerated
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stimulation of postsynaptic Glu receptors (GluRs) [8]. The
excessive influx of ions (especially Ca2+) into the postsynaptic neurons leads to their cell death via a spectrum of
mechanisms that range from necrosis (at the core of the
ischemic damage) to apoptosis or even recovery (at the
penumbra). Despite our familiarity with the first few steps
in excitotoxicity, our understanding of the steps following
Ca2+ influx is very limited. Clinical trials using GluRs antagonists ended with disappointment, and recent data suggests that using antagonists to block GluR functions might
be counterproductive, because Glu signaling includes both
neurotoxic and pro-survival cascades [9,10]. These complications emphasize the need to illuminate cell-deathspecific signaling cascades in excitotoxicity downstream of
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GluRs. A considerable number of such excitotoxic mechanisms have been suggested, but in many cases the data
that supports a given suggestion is limited to specific excitotoxic paradigms.
One suggested mediator of excitotoxicity implicated in
multiple experimental setups is the CaM-dependent
Death Associated Protein Kinase (DAPK) [11-14]. Originally identified by an unbiased screen for mediators of
interferon-induced cell death [15], DAPK was later recognized as a molecular switch that controls the choice
between cell death processes such as apoptosis and
autophagy [16,17]. Moreover, an elaborate web of biochemical interactions and functional connections has
been revealed, placing DAPK in a key position at the
center of many critical signaling cascades [11,18]. A considerable body of evidence suggests that DAPK also
contributes to cell death in excitotoxicity [19], and its
inhibition reduces neuronal loss in models of brain ischemia [20]. Several mechanisms have been suggested to
explain DAPK’s involvement in excitotoxicity, but the
issue remains controversial. One possible mechanism involves DAPK’s regulation of autophagy [17], a process
that modulates some neurodegenerative conditions [21].
Alternatively, an intriguing study suggests the involvement of DANGER, a protein that contains a region of
homology to the nematode protein MAB-21 and functions as a regulator of the IP3R [22]. Indeed DANGER
was found to also interact with and inhibit the activity of
DAPK [23]. The most cited suggestion in the field attributes the involvement of DAPK in excitotoxicity to the
potentiation of Ca2+ currents through NR2B/GluN2B
subunit-containing complexes of the NMDA- receptor
(NMDA-Rs) family of GluRs [24]. This suggestion fits
well with a proposed leading role for extrasynaptic
NR2B/GluN2B –containing NMDA-Rs in excitotoxicity
[25]. However, recently the proposed unique significance
of NR2B/GluN2B –containing extrasynaptic NMDA-Rs
in excitotoxicity has been brought into question [26-28].
Moreover, an earlier study suggests that in some mammalian neurons DAPK knockout provides protection
from excitotoxicity that is not dependent on NMDA-Rs
[29]. Indeed, some cases of excitotoxicity are mediated
by another family of GluRs, the Ca2+ -Permeable AMPA
Receptors (CPARs) [30-32]. These observations suggest
that if DAPK is widely involved in excitotoxicity, including
in cases where NR2B/GluN2B is not a main determinant
of neurodegeneration, it might act through additional
mechanisms to exert its effect.
We hypothesize that many signaling cascades might be
involved in specific cases of excitotoxicity, depending on
the exact scenario being used to induce it. However, the
key features that constitute the core of the excitotoxic
process might be conserved across differences in cell
death scenarios and large evolutionary distances, as is
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the case in apoptosis [33,34] and autophagy [35,36]. We
therefore set out to study the role of DAPK in excitotoxicity in our model of CPAR-mediated neurodegeneration in C. elegans [37], where GluR-dependent necrosis
of central neurons postsynaptic to Glu connections is
triggered by knockout (ko) of the GluT gene glt-3 [38] in
a sensitized background (nuIs5 [39]). Indeed, this model
has proven effective in identifying core processes that are
conserved between nematode and mammalian excitotoxicity [37,40,41]. DAPK is particularly well conserved in
C. elegans (in 52% sequence homology, presenting all of
DAPK’s functional domains, and in its involvement in a
number of signaling cascades [42-44]). The nematode
DAPK-1 is widely expressed (including in neurons [42]),
allowing us to test its involvement in nematode excitotoxicity and to study its mechanism of action. In this study
we establish the central role of DAPK in Glu-triggered
neurodegeneration in C. elegans, suggesting that its
function is conserved across evolution and excitotoxic
scenarios. We find little or no support for the views that
DAPK’s regulation of excitotoxicity is mediated through the
modulation of synaptic strength, MAB-21, or autophagy.
Instead, we identify PINN-1, the nematode homolog of the
DAPK-interaction-partner and phosphorylation-dependent
peptidyl-prolyl isomerase Pin1, as an important factor in
nematode excitotoxicity.

Results
DAPK-1 has a central role in nematode excitotoxicity

To test the involvement of DAPK in nematode excitotoxicity we combined our excitotoxicity strain (glt-3;nuIs5)
with a deletion allele of the nematode homolog of DAPK,
dapk-1(gk219), a gene knockout that was used to confirm
the effect of the (ubiquitously expressed) nematode DAPK
in autophagy and innate immunity [42,45]. In our previously described model of neurodegeneration we use the
sensitizing transgenic modification nuIs5, where hyperactive Gαs and GFP are expressed under the glr-1 promoter in ~30 neurons [39] and cause GluR-independent
stochastic degeneration of ~1 of these at-risk neurons per
animal. When we add the KO of the GluT gene glt-3 we
observe that more of these at-risk neurons degenerate
[37]. The GluT-KO-triggered exacerbated necrosis in
glt-3;nuIs5 is GluR-dependent, and therefore qualifies
as nematode excitotoxicity. Nematode excitotoxicity
causes neuronal swelling and death that is manifested
with characteristic kinetics as gradually and stochastically
appearing vacuole-like structures in some of the at-risk
postsynaptic neurons. These vacuole-like structures become more abundant during larval development as the
Glu signaling system matures (usually reaching up to ~4.5
head neurons/animal at L3), and then decline due to removal of cell corpses by engulfment [37]. We now observe
that adding dapk-1 ko to this excitotoxicity strain causes a
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strong and statistically significant suppression of neurodegeneration throughout development (Figure 1A, an
additional independent cross gave very similar results, not
shown). To further confirm the contribution of dapk-1 to
nematode excitotoxicity, we overexpressed the wt dapk-1
cDNA from an extra-chromosomal transgenic construct
under a heat-shock promoter [42]. Since heat-shock might
affect susceptibility to neurodegeneration, we took special
care to compare an exact match of treated animals,
without or with the dapk-1 overexpression transgene.
To that end we took advantage of the fact that the random and partial segregation of the non-integrated overexpression construct allows us to compare transgenic and
non-transgenic animals on the same plate exposed to the
same conditions. We observed that dapk-1 overexpression

Figure 1 dapk-1 is an important mediator of nematode excitotoxicity.
A) Dynamics of neurodegeneration in nematode excitotoxicity during
development (using the glt-3;nuIs5 excitotoxicity model). dapk-1 ko
mutation suppresses neurodegeneration in all developmental stages,
but does not bring it down to background levels. B) Overexpression of
wt dapk-1 from a heat-shock promoter enhances neurodegeneration
compared to matched controls. In all bar graphs, error bars represent SE.
Statistical significance is calculated using z score. *p < 0.05; ***p < 0.01.
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resulted in a strong and statistically significant potentiation
of necrotic neurodegeneration in postsynaptic neurons in
all developmental stages (Figure 1B). Together, our data indicate that DAPK is an important mediator of excitotoxicity
in C. elegans, suggesting that diverse scenarios of excitotoxicity share a common mechanism that assigns a central
role to DAPK.
dapk-1 ko does not alter presynaptic release or
postsynaptic Glu response

We used two main guidelines in trying to track the
mechanism by which dapk-1 regulates excitotoxic neurodegeneration in the nematode: 1) we looked at previous reports suggesting specific mechanisms for DAPK’s
involvement in mammalian excitotoxicity; 2) we inferred
from the general map of DAPK’s connectome in other
cell processes [18] which additional proteins are plausible candidates for mediating DAPK’s effect in nematode
excitotoxicity. One line of evidence suggests that DAPK
interacts with, and may regulate the function of, Syntaxin 1A [46]. Syntaxin is part of the general mechanism
of vesicular neurotransmitter release, a mechanism that
is shared among all neurotransmitters [47]. Therefore,
an effect of dapk-1 ko on any component of the synaptic
vesicle release could lead to DAPK-mediated changes in
excitotoxicity levels. However, given the ubiquitous expression of this gene, such an effect of DAPK on the
common synaptic vesicle release mechanism will affect
the dynamics of neurotransmitter release in all synapses.
The study of synaptic vesicle release is very well developed in the nematode, and aldicarb is routinely used in
C. elegans to identify mutations that cause even modest
changes to the general synaptic release mechanism [48].
As aldicarb suppresses the degradation of Acetylcholine
in the neuro-muscular junction, it causes animal paralysis with a typical dynamics. Mutations that reduce the
activity of the general, common vesicle release mechanism (such as rab-3 [48]) cause a pronounced resistance
to aldicarb (shifting the time-dependent paralysis curve
to the right, Figure 2A), while mutations that enhance
synaptic release (such as the ko of cpx-1, which encodes
the synaptic vesicle release regulator complexin [49]) cause
increased sensitivity to aldicarb (shifting the paralysis curve
to the left, Figure 2A). We observed that the sensitivity of
dapk-1 animals to aldicarb is indistinguishable from that of
WT animals, suggesting that dapk-1 ko does not modify
the synaptic release mechanism, as would have been
expected of an effect on syntaxin (Figure 2A).
We next asked if DAPK modifies the extent of postsynaptic response in the glutamatergic synapses where excitotoxicity occurs (as reported in mammals, where DAPK
was suggested to modify synaptic strength [24]). Two behavioral assays have proven very effective in detecting
even small changes in the activity level of glutamatergic
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Figure 2 The effect of dapk-1 does not correlate with several proposed mechanisms. A) Aldicarb assay measures the overall activity of the common
mechanism of synaptic vesicle release. Complexin (cpx-1) mutant is used as example of an oversensitive mutant (where synaptic release is exaggerate),
while rab-3 serves as an example of aldicarb resistant mutant (where synaptic release is abnormally low). dapk-1 mutants do not show oversensitivity or
resistance, suggesting their level of synaptic release is roughly normal. B) Duration of forward runs during spontaneous mobility is a sensitive reporter
of the overall strength of Glu synapses that control this parameter. Even small changes in the activity or number of GluRs typically modify this behavior.
dapk-1 mutants are not different from normal counterparts in either a WT background, in an excessive Glu stimulation background (glt-3),
or in the sensitized background (nuIs5) used in our excitotoxicity model. These three conditions by themselves do not cause excessive command neuron
loss, a loss that might otherwise render the assay uninformative as it is suppressible by dapk-1. C) A mutation in the gene encoding the DANGER-related
protein MAB-21 does not affect nematode excitotoxicity. D) A mutation in the gene encoding the nematode homolog of CaMKK does not
affect nematode excitotoxicity.

synapses in C. elegans. These are the Nose Touch
(NOT) assay, and the duration of spontaneous forward
mobility assay. Therefore, if dapk-1 ko causes changes in
the specific Glu packaging mechanism in synaptic vesicles
(e.g., by affecting vGluTs), or changes the number or
activity-level of GluRs in the synapse, this should be
reflected in behavioral changes in these assays. In the particular case of dapk-1, a secondary phenotype of this mutation, namely overgrowth of cuticle on the animal’s nose
[42], makes the nose-touch assay less informative. However, the duration of spontaneous forward mobility depends on the internal balance between forward and

backward circuits, and should not be affected by the cuticle aberration. This assay is very reliable in detecting
both under-activity and over-activity of the relevant Glu
synapses [50-52], allowing us to use it as a proxy measure
for Glu synaptic strength. We did not observe any changes
in spontaneous mobility triggered by dapk-1 ko, either in
WT background or in the background of each of the two
components (glt-3 or nuIs5) used in our excitotoxicity
model to trigger the intensified Glu signaling (Figure 2B).
These observations suggest that dapk-1 has no strong effect on synaptic release or the overall strength of signaling
in Glu synapses in C. elegans.
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The DANGER-related protein MAB-21 and the CaMKK
CKK-1 do not exert strong regulation of nematode
excitotoxicity

The characterization of DAPK as a CaM-dependent kinase
is particularly intriguing to us, since Ca2+ signaling is critical to excitotoxicity in both mammals and nematodes. We
therefore examined DAPK-partners that might also be involved in Ca2+ signaling. DANGER is a mammalian DAPK
inhibitor that regulates Ca2+ release from the ER [22,23].
There is no direct, full-length homolog of DANGER in
the worm genome, but the core of the mammalian protein is thought to be homologous to the nematode protein MAB-21 [53]. It is therefore reasonable to assume
that mab-21 will be essential to the role of a hypothetic
DANGER-like complex in C. elegans. However, a mutation in mab-21 had no effect on nematode excitotoxicity (Figure 2C). Another important protein that binds
mammalian DAPK and is involved in Ca2+ signaling is
CaMKK. However, again, a mutation in the only CaMKK
gene in the worm, ckk-1 [54], had no effect on excitotoxicity
(Figure 2D). These results suggest that these two putative Ca2+ signaling regulators and DAPK-interactionpartners do not have a large contribution to nematode
excitotoxicity.
We also considered the many other proteins that are
known to interact with DAPK [18] as possible modulators
of excitotoxicity, but we could not assign to many of them
high priority because either there was no immediate obvious connection to neurodegeneration (e.g., tropomyosin),
there is no clear nematode homolog (e.g., NFκB), the
nematode homolog is not known to be active in C. elegans
neurons (e.g., p53), or the process in which this protein is
involved has been shown by us to be not involved in
nematode excitotoxicity (e.g., apoptosis [41]). However,
DAPK is also known to interact with Beclin1, a key regulator of the evolutionary conserved process of autophagy,
suggesting that autophagy-mediated cell death could potentially be an avenue for DAPK to regulate nematode
excitotoxicity.
Autophagy has a minor role in nematode excitotoxicity

The interaction between mammalian DAPK and Beclin1
is considered a major avenue for DAPK’s ability to regulate
autophagy [11,16,17,55]. Autophagy has been suggested to
be an important factor in some neurodegenerative conditions [21,56,57], and has also been shown to be a major
contributor to degenerin-mediated neurodegeneration in
the nematode [58-60] (where necrotic neurodegeneration
is triggered by a constitutively open channel of the DEG/
ENaC family [61]). Moreover, dapk-1 regulates autophagy
in C. elegans [43]. We therefore set out to determine the
role of autophagy in nematode excitotoxicity, using
some of the same reagents used to demonstrate autophagy’s role in degenerin-induced neurodegeneration in
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the worm [58,60,62]. One such reagent is the red fluorescent labeled LC3 –homolog LGG-1 (originally created by the Tavernarakis lab [62], for the current study
assigned the strain name IMN21). This reporter indicates elevated autophagy by both the appearance of
intracellular puncta and by an overall increase in cellular fluorescence. We crossed IMN21 with our excitotoxicity strain glt-3;nuIs5. Since the red fluorescence
can appear in any body cell that triggers autophagy, we
used the Pglr-1::GFP marker expressed in our excitotoxicity strains to focus our attention on the postsynaptic
neurons that are at risk for neurodegeneration. If autophagy is a strong component of excitotoxicity, we
would expect at-risk neurons (labeled with GFP) to express
autophagy marker (DsRed) upon exposure to high concentrations of Glu (triggered by the glt-3 ko). We counted the
number of at-risk neurons that show LGG-1 puncta and
measured the overall intensity of DsRed::LGG-1 signal
in these neurons. Since autophagy was reported to have
a role in the low-level neurodegeneration caused by
nuIs5 alone [60], we concentrated on the added effect
of excitotoxicity by comparing DsRed::LGG-1 signals in
animals that express only the sensitizing construct
nuIs5 to those of animals in which neurons are subjected to the full excitotoxic insult (glt-3;nuIs5). We
found that excitotoxicity resulted in only a small and
statistically-insignificant increase in LGG-1 puncta, and
no change in overall LGG-1 intensity in at-risk neurons
(Figure 3A and B).
To further study the possible involvement of autophagy
in nematode excitotoxicity we examined the effect of inhibiting autophagy by genetic and chemical means. While a
number of mutations and drugs have been used in the
past, not all of them are available to us here. For example,
bec-1 ko was previously used to monitor the requirement
of this autophagy regulator for mec-4(d) –induced necrosis
in early development [58]. However, the lethal effect of
this mutation in later development, when most of the
nematode excitotoxic necrosis occurs, prevents us from
using this approach. Similarly, the vacuolar-type ATPase
inhibitor bafilomycin is commonly used to block autophagy by elevating lysosomal pH [63]. However, the same
V-ATPase is used in neurons to acidify synaptic vesicles
as a means to provide the driving force for neurotransmitter loading [64-66], and therefore using bafilomycin
can be expected to reduce neurotransmitter release.
We therefore turned to use other means of intervention
that are more compatible with our system: a mutation in
the autophagy regulator unc-51 (using the e369 allele) and
the chemical inhibitor 3MA (both used previously to show
that degenerin-triggered neurodegeneration in C. elegans
depends strongly on autophagy [58,60]). We noticed only
a moderate effect for these two factors, evident in some
developmental stages (Figure 4A and B). Such a moderate
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Figure 3 A DsRed::LGG-1 reporter of autophagy does not provide convincing evidence for triggering of autophagy in at-risk neurons exposed to
the excitotoxic insult. A) Representative images showing at-risk neurons in green (expressing Pglr-1::GFP) and DsRed::LGG-1 expressing cells in red.
Lateral view, anterior left, dorsal up, illustration on the left describing the results expected from a putative involvement of autophagy in excitotoxicity.
Expression of green labeling in the pharynx comes from the co-injection marker for the DsRed::LGG-1 label, expressing Pmyo-2::GFP. B) Analysis of images
taken from the two groups shows a similar number of at-risk neurons (green cells) showing DsRed::LGG-1 puncta. The observed small difference is not
statistically significant. (t test used here) C) The average intensity of the DsRed::LGG-1 signal in at-risk neurons (green) in very similar in the two groups.

effect is in line with the reported effect of unc-51 on nuIs5
alone [60] (see discussion). We then used an independent
set of experiments and epistasis analysis to determine if
this moderate effect works independently of dapk-1 or in
the same pathway. We noticed that the effect of blocking
autophagy on the extent of excitotoxicity is reproducible
only in one developmental stage (L3). Trying to determine
if dapk-1 and 3MA work in the same pathway, we compared their observed combined effect (in the dapk-1 +
3MA combination) to the calculated expected effect if
these two processes were completely independent. However, given the moderate size of the 3MA effect and the inherent variability in our experiments, it is currently
difficult to determine if dapk-1 and autophagy work in the

same pathway or independently. Nonetheless, the fact that
the effect of autophagy is much more limited in size and
duration than that of dapk-1 supported a continued search
for other mechanisms by which dapk-1 might regulate
excitotoxicity.
The DAPK interaction-partner and phosphorylationdependent peptidyl-prolyl isomerase Pin1/PINN-1 is a
conserved suppressor of neurodegeneration

Pin1 is an isomerase that changes the conformation of
proline residues located next to phosphorylated Ser or
Thr residues, thus changing overall protein conformation
and controlling the activity of many phosphoproteins
[67,68]. In recent years this protein has gained recognition
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Figure 4 Treatments that block autophagy (and dramatically reduce
neurodegeneration in other forms of necrotic neurodegeneration
in C. elegans) have a reproducible but small effect in nematode
excitotoxicity. A) A mutation in unc-51 shows a moderate effect on
nematode excitotoxicity. *p < 0.05 ; ***p < 0.01 B) Treatment with the
autophagy-blocking drug 3MA has a moderate effect on nematode
excitotoxicity. ***p < 0.01 C) Independent repetition of the experiment
shown in B with the addition of epistasis analysis. The data shows that
the only reproducible effect of autophagy blockade is in L3. Although
at this stage the combined effect of autophagy blockade and dapk-1
correlates with a model of independent action of these two factors,
the moderate extent of effects limits the strength of such a conclusion.
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as a major regulator of many signaling cascades, involved
in both normal cell physiology, pathology, and in neurodegenerative diseases [67,69-71]. Pin1 is expressed in dendrites, its activity is modulated by Glu signaling, and it
regulates PKCζ and PKMζ [72,73]. Pin1 is also known for
its regulation of neuronal cytoskeleton and Tau protein
phosphorylation, and for modulating neurodegeneration
[69,74,75]. Recently, Pin1 was shown to functionally interact with DAPK [76]. We find that pinn-1 ko [77] causes increased neurodegeneration in nematode excitotoxicity
(Figure 5). Like dapk-1 ko, the effect of pinn-1 ko is seen in
all developmental stages (Figure 5A), and does not seem
to involve a change in Glu synaptic strength (Figure 5B
and C), suggesting that they influence cell-death processes
subsequent to- (and not at the level of-) GluR.
We wished to confirm that the effects of dapk-1 and
pinn-1 on the dynamics of vacuolar appearance (as seen
in Figures 1A and 5A) translate to ultimate survival of
specific neurons in adult animals. Given the stochastic
nature of neurodegeneration in glt-3;nuIs5 animals, it is
usually difficult to identify which of the ~30 at-risk head
neurons are degenerating in different animals. To circumvent this difficulty, we address the survival of specific neurons by focusing on the easily identifiable RIG
neurons. The RIG neurons are part of the group of atrisk head neurons, they show only very minor levels of
neurodegeneration in nuIs5 alone, and they are sensitive
to all the treatments that modify total head neuron degeneration analyzed in our previous studies [37,40,41].
Indeed, RIG neurons exhibit inverse correlation between
the number of vacuole-like structures they show during
development (as observed by Nomarski) and the number
of GFP-labeled RIG neurons surviving in the adult [37].
We now confirm that the number of degenerating RIG
neurons during development is reduced by dapk-1 ko
and increased by pinn-1 ko (data not shown). Importantly, we find that the number of GFP-labeled RIG neurons that survive to adulthood is increased by dapk-1 ko
and decreased by pinn-1 ko (Figure 6B). These observations suggest that the effects of dapk-1 and pinn-1 on
vacuolar appearance during development indeed translate to changes in ultimate survival of identified neurons.
Finally, we wanted to determine if dapk-1 (where a
KO causes decreased neurodegeneration) and pinn-1
(where a KO causes increased neurodegeneration) work
in the same or separate pathways. Mammalian studies
suggest that DAPK is acting upstream of Pin1 to inhibit
its function [76], so that KO of pinn-1 could be expected
to exert its death-stimulating effect regardless of whether
dapk-1 is present or not. Instead, using epistasis analysis
(Figure 6A), we observe that the double knockout dapk-1 ;
pinn-1 exhibited suppression of excitotoxicity. We tried to
further determine if the effect of dapk-1; pinn-1 double
knockout reflects an intermediate outcome (in line with
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Figure 5 pinn-1 is an important suppressor of nematode excitotoxicity that does not affect basic synaptic strength. A) pinn-1 mutation enhances
excitotoxicity throughout development. **p < 0.01 B & C) pinn-1 does not affect the duration of spontaneous forward mobility or nose touch sensitivity,
two sensitive measures of Glu synaptic strength.

an independent, parallel effect of these two factors) or a
dapk-1 ko –only-like outcome (in line with an obligatory
sequential effect, where the dapk-1 mutation-induced decrease in neurodegeneration completely masks the ability
of pinn-1 mutation to increase neurodegeneration). To
that end we calculated what would be the effect of these
two factors acting in parallel, to predict their cumulative
independent effect (Figure 6A). Unfortunately, the small
difference between the observed effect of dapk-1 alone
and the calculated independent cumulative effects of
dapk-1 and pinn-1, together with the variability in our
data, do not allow us to discriminate with confidence between these two options. We therefore limit our conclusion to say that dapk-1 acts either downstream or in
parallel to- (but not upstream of-) pinn-1 in nematode
excitotoxicity.

Discussion
Mammalian studies have generated a plethora of proposed mechanisms in excitotoxicity, and some of these
studies include suggested pathways for the involvement
of DAPK in critical cell death events. However, the

significance of these proposed mechanisms across divergent excitotoxic conditions remains unclear. In our
study we focused on a glutamate-dependent neuronal
death in C. elegans and examined a set of candidate
mechanisms to define those that might be conserved
through a large evolutionary distance. We previously
found that some core constitutes of excitotoxicity are
well conserved in our nematode model of GluT KO –
triggered and CPAR-mediated neuronal necrosis. These
include both death-promoting factors (such as release of
Ca2+ from the ER [37]), and neuroprotective factors
(such as cell stress resistance to insults, resistance that is
conferred by FoxO/DAF-16 [40,41]). We now report that
DAPK is also a highly conserved regulator of excitotoxicity (Figure 1A and B), though we note that dapk-1 ko
does not bring neurodegeneration all the way down to
background levels. We find no evidence for dapk-1 –
mediated regulation of synaptic strength, as defined by
the spontaneous mobility assay (Figure 2B), suggesting
that the effect of DAPK on mammalian NR2B/GluN2B,
though probably very important, does not extend to all
forms of excitotoxicity. We also found no role for the
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Figure 6 dapk-1 might cooperate with pinn-1 to regulate nematode excitotoxicity. A) Epistasis analysis testing the involvement of dapk-1 and
pinn-1 in nematode excitotoxicity. Since the combined mutant shows strong suppression of neurodegeneration compared to the starting strain,
these observations strongly suggest that pinn-1 is not downstream of dapk-1 (though the data is not conclusive enough to choose between the
possibilities of pinn-1 acting upstream or independently of dapk-1). B) Verification that the effects of dapk-1 and pinn-1 mutations on the
dynamics of overall neurodegeneration in head neurons translates to survival of identified neurons in the adult (counting surviving GFP-labeled
RIG neurons in young adult animals). C) One of the likely models that can account for our observations on the role of DAPK-1, PINN-1, and
autophagy in nematode excitotoxicity.

DANGER-related protein MAB-21 in nematode excitotoxicity (though DANGER is a much larger protein than
MAB-21, suggesting it might have additional functions
not tested here).
Although dapk-1 is an important regulator of autophagy
in C. elegans, we find only a minor role for autophagy in
the neurodegenerative condition we study in glt-3;nuIs5 animals. We find that blocking autophagy has a relatively
small neurodegeneration-reducing effect (~0.5-1 dying
neuron/animal, Figure 4). This effect is smaller than the
neurodegeneration-suppressing effect of dapk-1 ko (a decrease of ~2.5 dying neurons/animal, three independent
isolates counted in Figures 1A, 4C, and 6A). Therefore,
even if related, autophagy cannot account for the majority
of DAPK’s effect in glt-3;nuIs5 animals. The minor effect of
autophagy on neurodegeneration in glt-3;nuIs5 is in sharp
contrast to the major effect that autophagy has on

degenerin-mediated neurodegeneration, where it suppresses neurodegeneration by 75-90% [60]. We further
note that these previous studies have demonstrated that
blocking autophagy decreases the extent of low-level
neurodegeneration triggered by nuIs5 alone [60]. Since
neurodegeneration by nuIs5 alone (independent of
excitotoxicity) is part of the total number of degenerating neurons we count in our assay (accounting for ~1
dying neuron/animal [37]), the small effect of autophagy seen in the current study can be attributed to its
documented effect of nuIs5 alone. Indeed, we see no
significant difference in labeling of fluorescent autophagy reporter when comparing nuIs5 to glt-3;nuIs5
animals (Figure 3). The results of epistasis analysis are
not conclusive, but put together with the difference in
size and timing of the effects of dapk-1 and autophagy
on nematode excitotoxicity, our observations cause us
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to favor one of the possible models in which autophagy
has only a minor role in nematode excitotoxicity in parallel to the role of DAPK-1 (Figure 6C). We emphasize that
the parallel action of DAPK and autophagy is preferred by
us in the specific scenario of nematode excitotoxic stress,
while other stresses might include DAPK and autophagy
in other pathway configurations.
The observation that the DAPK-interaction-partner
Pin1/PINN-1 is a significant regulator of excitotoxicity is
particularly intriguing and novel. In addition to its involvement in cancer [71] and stress response [78], Pin1 has
been shown to be a critical regulator of dendritic Glu responses [72,73] and of neurodegeneration in Alzheimer
disease [69,74,75]. The results of our epistasis analysis do
not seem to support a role for Pin1/PINN-1 as an obligatory step downstream of DAPK/DAPK-1, as might be
inferred from mammalian cancer studies [76]. Instead, our
data supports that PINN-1 acts in parallel or upstream of
DAPK-1 (Figure 6A and C).

Conclusions
Put together, our study suggests that nematode excitotoxicity can be an important tool to sift through many
proposed mechanisms of excitotoxicity, allowing us to
identify conserved mechanisms that might be at the core
of neurodegenerative processes common across divergent excitotoxic scenarios. Furthermore, our studies now
illuminate DAPK/DAPK-1 and Pin1/PINN-1 as two such
factors, important for excitotoxicity mechanisms across
a large evolutionary distance. We can now further use
this system to decipher DAPK-1 and PINN-1 –related
mechanisms in nematode excitotoxicity, with the hope
that such understanding might help us to continue
uncovering conserved core mechanisms in this important form of neurodegeneration.
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strain naming here as per BMC policy) IMN21: N2; Ex
[Plgg-1:: DsRed:: LGG-1; Pmyo-2:: GFP]; Glu-regulated mobility defective control: VM1268: nmr-1(ak4) II; glr-2(ak10)
glr-1(ky176) III; DANGER-related protein MAB-21:
EM128: mab-21(bx53) III (Q203* , CAG – > UAG) (RRID:
CGC_EM128). CaMKK-like KO: ckk-1(ok1033) III (RRID:
CGC_VC691); Pin1-like KO: pinn-1(tm2235) II (this
364 bp deletion runs the ORF into a stop codon after 8 codons). Most crosses were followed by PCR analysis to detect deletions, and by monitoring nuIs5’s GFP expression in
glr-1-expressing interneurons using a high power fluorescence dissecting scope. dapk-1 over-expressing construct
juEx1933 was followed by its coinjection marker, which
produces RFP expression on AIY neurons. The unc-51
mutation was followed by uncoordinated phenotype
and sequencing. DsRed::LGG-1 was followed by DsRed
expression in cells throughout the body and by GFP expression in the pharynx (from the myo-2 promoter).
We constructed the following strains: dapk-1 in excitotoxicity (by crossing VC432 and ZB1102) IMN26:
dapk-1(gk219) I; glt-3(bz34) IV; nuIs5 V; DAPK-1 overexpression in excitotoxicity (by crossing ZB1102 and
CZ9277) IMN25: glt-3(bz34) IV; nuIs5 V; juEx1933
[Phsp16::DAPK-1; Pttx-3::RFP]; Autophagy suppression
in excitotoxicity (by crossing ZB1102 and CB369)
IMN22: glt-3(bz34) IV; nuIs5 , unc-51(e369) V; Autophagy reporter in excitotoxicity IMN24: glt-3(bz34)
IV; nuIs5 V; Ex[Plgg-1:: DsRed:: LGG-1; Pmyo-2:: GFP];
CaMKK deletion in excitotoxicity: ckk-1 (ok1033) III;
glt-3(bz34) IV; nuIs5 V. DANGER-like deletion in
excitotoxicity: (by crossing EM128 and ZB1102): mab21(bx53) III; glt-3(bz34) IV; nuIs5 V; Pin1-like deletion
in excitotoxicity: IMN30: pinn-1(tm2235) II; glt-3(bz34)
IV ; nuIs5 V (± dapk-1(gk219) I).
Neurodegeneration analysis

Methods
Strains

The following C. elegans strains were obtained from the C.
elegans Genetic Center (CGC), from the Japanese National
Bioresource Project (NBSP), or from the original producers: WT: Bristol N2 (RRID:CGC_N2 (ancestral));
Nematode excitotoxicity model: ZB1102: glt-3(bz34) IV;
nuIs5 V; (RRID:CGC_ZB1102) dapk-1: VC432: dapk1(gk219) I; (RRID:CGC_VC432) dapk-1 over-expression:
CZ9277: frIs7[Pnlp-29::GFP; Pcol-12:DsRed] (IV); juEx1933
[Phsp16::DAPK-1; Pttx-3::RFP] (the frIs7 insertion was later
eliminated during our cross); Aldicarb assay control
strains: sv-hyper-releasing/aldicarb-oversensitive RB1367:
cpx-1(ok1552) (RRID:CGC_RB1367); sv-under-releasing/
aldicarb-resistant NM791: rab-3(js49) (RRID:CGC_NM
791): Autophagy modulator unc-51: CB369: unc-51
(e369) V (RRID:CGC_CB369); Autophagy label, DsRed
::LGG-1: (originally created by the Tavernarakis lab [62],

The level of necrotic neurodegeneration in head neurons
was monitored using an inverted scope and Nomarski
Differential Interference Contrast (DIC). Animals with
no anesthetics were examined on a fresh chunk of agar
of nematode culture flipped upside down over a slide.
Swollen “vacuolated-looking” cells located in the area of
the nerve ring were counted as head neurons undergoing necrosis, as described previously [37,41]. Briefly, we
use freshly growing mixed-stage animals, and we record
the developmental stage and the number of “vacuolated”
dying neurons of each animal that we see while scanning
through the agar chunk, thus creating a “snap-shot” of
the transitory number of dying neurons exhibited by the
population of animals at the time of analysis. As mentioned above, in the excitotoxicity strain the number of
“vacuolated” cells observed at each developmental stage
typically goes up until L3 (with the maturation of Glu signaling in the worm), and then declines with the engulfment
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of cell copses. This analysis is repeated several times, with
several isolates of each strain. For confirmation of suspected effects in new mutant combinations, a representative part of the analysis is done blindly by independent
observers. Similar numbers of control and test animals are
recorded in each session. Records from all these sessions is
pooled together to calculate average neurodegeneration
from large number of animals in each strain and each stage
(50–200 in each data bar). We occasionally confirmed
these dying neurons as neurons postsynaptic to Glu
connections by verifying their labeling with the GFP coexpressed in nuIs5 animals under the glr-1 promoter. For
heat-shock-induced overexpression of DAPK-1, animals
carrying [Phsp16::DAPK-1; Pttx-3::RFP] were placed in a
35°C incubator for 2 hours to induce activation of heat
shock promoter, left to rest for about 30 minutes and
scored regularly for two days for the extent of swollen
degenerating neurons (protocol & strains coordinated
with the Chisholm group, UCSD [42]). Experimental
animals (animals with extrachromosomal array) and
control animals (animals lacking extrachromosomal
array) were obtained, identified and scored on the same
day from the same pool of heat-shocked animals. For epistasis analysis between given excitotoxicity-modifying mutations X and Y, we calculated the effect of each mutation
for each developmental stage as: Fold effect of X = (the
average number of dying head neuron in the excitotoxicity
strain in the presence of mutation X)/(the average number
of dying head neuron in the starting excitotoxicity strain),
with a similar calculation for mutation Y. The expected
cumulative fold effect of mutations X and Y when working
independently in parallel pathways is (fold effect of X) *
(fold effect of Y). The calculated expected number of
dying neurons presented on the graphs in Figures 4 and 6
is (the average number of dying head neuron in the starting excitotoxicity strain) * (fold effect of X) * (fold effect
of Y). Error bars represent SE. Statistical significance of
difference between control groups and experimental
groups was analyzed using z-test score (as the significance
of these differences is calculated for large populations
of ~100 animals in each group).
Fluorescence microscopy analysis of autophagy

Animals carrying Ex [Plgg-1:: DsRed:: LGG-1; Pmyo-2::
GFP]; glt-3(bz34) IV; nuIs5 V and Ex [Plgg-1:: DsRed::
LGG-1; Pmyo-2:: GFP]; nuIs5 V were analyzed for the extent to which glr-1 expressing command interneuron (labeled with GFP) were undergoing autophagy (i.e., show
DsRed punca or increased DsRed intensity). Animals
were mounted on a 2% agar pad. To compare average
DsRed intensity between worms we identified the cell
with the highest DsRed intensity as 100% and then compared the other neurons to this cell (following the procedure used by the Tavernarakis lab, who developed this
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DsRed::LGG-1 marker [62]). A few cells were analyzed
in each animal and the average intensity from a total
from 20–25 animals was calculated. We also counted
the average of the number of green-labeled neurons
showing DsRed puncta as another indication of neurons
undergoing autophagy and compared control (nuIs5
only) versus experimental (glt-3; nuIs5) groups.
Blockade of autophagy with 3MA

For 3-methyladenine (3MA) treatment, mixed stage animals from the excitotoxicity strain (glt-3; nuIs5) or the
DAPK-inhibited excitotoxicity strain (dapk-1; glt-3; nuIs5)
were incubated overnight with 10 mM 3-MA (Sigma,
M9281) dissolved in 1% DMSO (experimental group) or
1% DMSO alone (control). Plates were supplemented with
E. coli OP50. The extent of neurodegeneration was recorded 20–24 h after treatment.
Behavioral assays

Behavioral assays on nematode locomotion and worm
paralysis were performed blindly following standard
methods of behavioral analysis. For duration of Gluregulated spontaneous forward mobility we followed the
protocol of the Maricq group (U Utah) [79]. We did not
measure mobility in strains that show excitotoxic neurodegeneration because the degeneration or rescue of
command interneurons can change the results of this
assay. For aldicarb assays we followed the Nonet lab
protocol (Washington U) [48]. Briefly, we soaked worm
plates with aldicarb to a final concentration of 0.5 mM
and added food. We placed ~30 freshly growing young
adult animal onto these plates. The percentages of paralyzed worms were recorded every 15 minutes for a period
of 2 hours.
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